Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Joint Bone Spine
|
July 29, 2015
Myositis ossificans circumscripta
Pauline Baudart, Johann Cesini, Emmanuel Meyer, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 13, 2014
Optimization of 2-phenyl-pyrimidine-4-carboxamides towards potent, orally bioavailable and selective P2Y(12) antagonists for inhibition of platelet aggregation
Eva Caroff, Emmanuel Meyer, Alexander Treiber, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 22, 2024
Oncological outcomes of patients with muscle-invasive bladder cancer treated with trimodal strategy: A French multicentric study
Carolinne Brassart, Alexandre Coutte, Jennifer Wallet, et al.
Cancers
|
January 21, 2023
Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study
Barbara Bailly-Caillé, Diane Kottler, Rémy Morello, et al.
Frontiers in Oncology
|
March 20, 2024
Stereotactic body radiotherapy as a viable treatment on extracranial oligometastases in melanoma patients: a retrospective multicentric study
Victorine Trentesaux, Sophie Maiezza, Emilie Bogart, et al.
Journal of Medicinal Chemistry
|
November 10, 2015
4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel
Eva Caroff, Francis Hubler, Emmanuel Meyer, et al.
International Journal of Colorectal Disease
|
December 20, 2019
Implantation of tissue expander prior to irradiation in the era of intensity modulated radiotherapy: impact on the management of patients with pelvic digestive cancers
Luc Ollivier, Jean Marc Guilloit, Mélanie Dos Santos, et al.
Frontiers in Oncology
|
June 18, 2024
Simultaneous integrated boost on pathologic lymph nodes safely improves clinical outcomes compared to sequential boost in locally advanced cervical cancer: a multicenter retrospective study
Marin Guigo, Mohammed Sali Dauda, Justine Lequesne, et al.
European Urology Oncology
|
May 11, 2024
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial
Loic Ah-Thiane, Loic Campion, Nedjla Allouache, et al.
Communications Medicine
|
December 23, 2025
Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancer
Antoine Boué, Giulia Baciarello, Emmanuel Meyer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Joint Bone Spine
|
July 29, 2015
Myositis ossificans circumscripta
Pauline Baudart, Johann Cesini, Emmanuel Meyer, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 13, 2014
Optimization of 2-phenyl-pyrimidine-4-carboxamides towards potent, orally bioavailable and selective P2Y(12) antagonists for inhibition of platelet aggregation
Eva Caroff, Emmanuel Meyer, Alexander Treiber, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 22, 2024
Oncological outcomes of patients with muscle-invasive bladder cancer treated with trimodal strategy: A French multicentric study
Carolinne Brassart, Alexandre Coutte, Jennifer Wallet, et al.
Cancers
|
January 21, 2023
Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study
Barbara Bailly-Caillé, Diane Kottler, Rémy Morello, et al.
Frontiers in Oncology
|
March 20, 2024
Stereotactic body radiotherapy as a viable treatment on extracranial oligometastases in melanoma patients: a retrospective multicentric study
Victorine Trentesaux, Sophie Maiezza, Emilie Bogart, et al.
Journal of Medicinal Chemistry
|
November 10, 2015
4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel
Eva Caroff, Francis Hubler, Emmanuel Meyer, et al.
International Journal of Colorectal Disease
|
December 20, 2019
Implantation of tissue expander prior to irradiation in the era of intensity modulated radiotherapy: impact on the management of patients with pelvic digestive cancers
Luc Ollivier, Jean Marc Guilloit, Mélanie Dos Santos, et al.
Frontiers in Oncology
|
June 18, 2024
Simultaneous integrated boost on pathologic lymph nodes safely improves clinical outcomes compared to sequential boost in locally advanced cervical cancer: a multicenter retrospective study
Marin Guigo, Mohammed Sali Dauda, Justine Lequesne, et al.
European Urology Oncology
|
May 11, 2024
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial
Loic Ah-Thiane, Loic Campion, Nedjla Allouache, et al.
Communications Medicine
|
December 23, 2025
Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancer
Antoine Boué, Giulia Baciarello, Emmanuel Meyer, et al.
Page
of 2